Grail Obtains $100,000,000 New Funding Round

  • Feed Type
  • Date
    1/13/2016
  • Company Name
    Grail
  • Mailing Address
    Undisclosed Venice, CA 90291 USA
  • Company Description
    The mission of Grail is to enable the early detection of cancer in asymptomatic individuals through a blood screen – with the goal of massively decreasing global cancer mortality by detection at a curable stage. Grail will leverage the power of Illumina next-generation sequencing technology, the best talent in the field and the passion of its leadership to deliver on that promise.
  • Website
    http://www.grailbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $100,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Investor
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Sutter Hill Ventures
  • Venture Investor
    Bezos Expeditions
  • Venture Investor
    Illumina

Trending on Xconomy